Author

Linhan Hu

Institution: Beijing University of Chinese Medicine

Observed institutions: Beijing University of Chinese Medicine, Inner Mongolia Medical University

ORCID: 0000-0003-4895-1203

Observed ORCID: 0000-0003-4895-1203

OpenAlex ID: A5014604436

Pathogenesis of allergic diseases and implications for therapeutic interventions

2023 · Ji Wang, Yumei Zhou, et al. · Signal Transduction and Targeted Therapy · 377

Guominkang formula alleviate inflammation in eosinophilic asthma by regulating immune balance of Th1/2 and Treg/Th17 cells

2022 · Yumei Zhou, Linhan Hu, et al. · Frontiers in Pharmacology · 25

TIM-1 Augments Cellular Entry of Ebola Virus Species and Mutants, Which Is Blocked by Recombinant TIM-1 Protein

2022 · Min Zhang, Xinwei Wang, et al. · Microbiology Spectrum · 12

pH Low Insertion Peptide-Modified Programmed Cell Death-Ligand 1 Potently Suppresses T-Cell Activation Under Acidic Condition

2021 · Ying Sun, Linhan Hu, et al. · Frontiers in Immunology · 9

Bioinformatics and Network Pharmacology Identify the Therapeutic Role of Guominkang in Allergic Asthma by Inhibiting PI3K/Akt Signaling

2025 · Honglei Zhang, Haiyun Zhang, et al. · Journal of Inflammation Research · 5

Exploring the Efficacy and Mechanism of Astragalus Polysaccharide in Treating Allergic Asthma through Network Pharmacology, Bioinformatics, and Experimental Verification

2025 · Linhan Hu, Haiyun Zhang, et al. · Combinatorial Chemistry & High Throughput Screening · 2

Monocytes Expressing IL ‐ 36G Play a Crucial Role in Atopic Dermatitis

2025 · Yitao Yang, Lei Wang, et al. · Journal of Cellular and Molecular Medicine · 2

The inhibition of CD4+ T cell proinflammatory response by lactic acid is independent of monocarboxylate transporter 1

2021 · Peng Yang, Ying Sun, et al. · Scandinavian Journal of Immunology · 1

Efficacy and safety of the Chinese herbal formula Guominkang for allergic rhinitis: A randomized, double-blind, placebo-controlled trial

2026 · Juntong Liu, Haiyun Zhang, et al. · Journal of Traditional Chinese Medical Sciences

Combining AlphaFold—based AI docking with omics technologies preliminarily unveils the mechanism of Guominkang in treating allergic rhinitis

2025 · Yumei Zhou, Longmei Yu, et al. · Scientific Reports

Works count: 10

Citation count: 433

H-index: 5

I10-index: 3